Original Article
Kidney International (2007) 71, 764–770. doi:10.1038/sj.ki.5002111; published online 7 February 2007
PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys
C C Tseng1,2, J J Huang1, M C Wang1, A B Wu1, W C Ko3, W C Chen4 and J J Wu5
- 1Division of Nephrology, Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- 2Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- 3Division of Infectious Disease, Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- 4Department of pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- 5Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Correspondence: JJ Wu, Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, No. 1 University Road, Tainan 70101, Taiwan. E-mail: jjwu@mail.ncku.edu.tw
Received 11 July 2006; Revised 22 November 2006; Accepted 28 November 2006; Published online 7 February 2007.
Abstract
Most human pyelonephritogenic Escherichia coli express the PapG II adhesin. However, the role of the PapG II adhesin in enhancing the establishment and persistence of E. coli infection in the kidney is controversial. A pyelonephritogenic strain, EC114, which possesses one copy of the papG II gene, but without other virulence factors (such as S/F1C-fimbriae, hemolysin, and cytotoxic necrotizing factor 1) was selected for the construction of a papG II mutant. The resulting papG II mutant was confirmed by polymerase chain reaction, Southern hybridization, and agglutination assay, and designated as MEC114. We compared MEC114 with the parental strain (EC114) for colonization ability in the bladder and kidney of female BALB/c mice, which were challenged transurethrally with 50
l of a low (5
104 CFU (colony-forming unit)) or high (5
108 CFU) dose of EC114 or MEC114 and assessed 1, 3, and 7 days after inoculation. Geometric means of quantitative bacterial counts in the kidney were significantly decreased when challenged with MEC114 on day 3 after inoculation, at both low and high dose (P<0.05), as compared with EC114. On the seventh day, both strains were mainly cleared from the kidney. Renal biopsy showed a similar degree of inflammatory response to both strains 1, 3, and 7 days after inoculation. In brief, the PapG II adhesin can enhance the early establishment of E. coli infection in the kidney, but the bacteria do not maintain infection owing to the host immune response.
Keywords:
acute pyelonephritis, PapG II adhesin, E. coli, mutant, infection, mice
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys
Kidney International Original Article
Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa
Kidney International Original Article
Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa
Kidney International Original Article
The EMBO Journal Article (03 Apr 2000)


